|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 12, 2016 ) GlobalDatas pharmaceuticals report, S-1 ( Cervical Cancer) - Analysis and Forecasts to 2020 provides S-1 sales forecasts for Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Cervical Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.
Scope
- Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
- Analysis and review of S-1 including sales data
- Qualitative and quantitative assessment of market space
- Analysis of the trends, drivers and restraints shaping and defining the markets
- In-depth analysis of S-1 including efficacy, safety, pricing, competition and other details which influence its sales potential
- Detailed sales forecasts for 2015-2020 for S-1 in Japan
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=28349
Reasons to buy
- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drugs performance
- Examine the historical sales performance of a drug in seven major markets
- Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Table of Contents
1 Table of contents 2
1.1 List of Tables 2
1.2 List of Figures 3
2 Introduction 4
2.1 Cervical Cancer Market 4
2.2 Epidemiology 4
2.3 Etiology 6
2.3.1 HPV Infections 6
2.3.2 Lack of Regular Papanicolaou (pap) Tests 6
2.3.3 Smoking 6
2.3.4 Sexual History 7
2.3.5 Birth Control Pills 7
2.4 GlobalData Pipeline Report Guidance 7
3 Cervical Cancer Disease: Market Characterization 8
3.1 Cervical Cancer Disease Market 8
3.2 Cervical Cancer Disease Market Forecasts and CAGR 8
3.3 Drivers and Barriers for the Cervical Cancer Market 9
4 Tumor-Node-Metastases (TNM) Classification of Cervical Cancer 10
5 S-1 135.1 Introduction 13
5.2 Mechanism of Action 13
5.3 Clinical Studies 13
5.4 Approval History of S-1 14
5.5 Factors Affecting Sales of S-1 14
5.5.1 Cervical Cancer Market in Japan 14
5.5.2 Oral Administration 14
5.5.3 Presence in Market Prior to Cervical Cancer 14
5.5.4 Lower Toxicity 14
5.5.5 Lack of Presence in the US and EU market 14
5.6 Drug Risk Benefit Score 15
5.6.1 Efficacy 15
5.6.2 Safety 15
5.6.3 Compliance 15
5.6.4 Dosing Convenience 15
5.7 Intensity of Competition 15
5.8 Sales forecast 16
5.8.1 Target patient Pool of S-1 16
5.8.2 Dosing 16
5.8.3 Market Penetration 17
5.8.4 Annual Cost of Therapy 17
5.8.5 Sales Projections of S-1 17
6 Appendix 19
6.1 Abbreviations 19
6.2 Research Methodology 19
6.2.1 Coverage 19
6.2.2 Secondary Research 20
6.2.3 Forecasting 20
6.2.4 Number of Patients Approved to take the Drug 20
6.2.5 Net Penetration of Drug 21
6.2.6 Net Annual Dosing 22
6.2.7 Annual Cost of Therapy 22
6.2.8 Primary Research 22
6.2.9 Expert Panels 22
6.3 Contact Us 22
6.4 Disclaimer 23
6.5 Sources 23
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=28349
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
